Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Dr. Sita Kugel receives V Foundation Translational Research Award
Grant makes possible a clinical trial of targeted treatment for pancreatic cancer
Dr. Sara Hurvitz joins Fred Hutch, University of Washington
Longtime UCLA breast oncologist and international expert will be senior vice president of the Clinical Research Division
Functionalizing the genome to find novel pancreatic cancer treatments
From the Kemp Lab, Human Biology Division
Structural landscape of DNA and precision medicine, firm handshake
From the Ha lab, Public Health Sciences and Human Biology Divisions
Inspiring Generosity: Gift to Fuel Multifaceted Approach to Discovery
Landmark donation from Bezos family to Fred Hutch will fund multiple scientific priorities, including clinical trials support, translational research capabilities and recruitment
Unlocking more information from liquid biopsies
Dr. Gavin Ha receives $1.5M NIH Director’s New Innovator Award for creative young scientists with high-risk, high-reward projects
Transformative $78M gift to establish new precision oncology institute
Gift will accelerate center’s leadership in the future of cancer research
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
Measure 170 times, cut once: high-throughput drug screening for multiple myeloma
From Dr. Pamela Becker and Dr. David Coffey, Clinical Research Division
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Tip Sheet: Looking ahead to 2021, COVID-19 vaccines, improving health outcomes — and more
Summaries of recent Fred Hutch research findings and other news
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Seeking targeted treatments for pancreatic cancer
American Cancer Society fellowship to Dr. Nithya Kartha supports search for vulnerabilities in most aggressive pancreatic tumor subtype
Experimental, precision strategy targets unique cancer protein found in certain acute myeloid leukemia cases
Lab study shows promise of aiming genetically engineered T-cell therapy at a gene fusion
A path opens for precise analyses of breast cancer proteins
Paulovich lab runs CLIA-cleared tests to find patients appropriate for new HER2-targeted therapies
Immune response in colorectal cancer: What helps, what hurts?
GECCO collaboration drills into mechanisms of specific T-cell response to germline variations, lifetime exposures and tumor environment
2 Fred Hutch leaders receive PSBJ Health Care Leadership Awards
Puget Sound Business Journal honors Drs. Gary Gilliland, Nancy Davidson among 16 regional health care leaders